Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis.

Bascuñana, Pablo; Möhle, Luisa; Brackhan, Mirjam; Pahnke, Jens

Bascuñana, Pablo; Möhle, Luisa; Brackhan, Mirjam; Pahnke, Jens.

Affiliation

Bascuñana P; Department of Neuro-/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway. pablo.bascunana@medisin.uio.no.
Möhle L; Department of Neuro-/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway.
Brackhan M; Department of Neuro-/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway.
Pahnke J; Department of Neuro-/Pathology, University of Oslo (UiO) and Oslo University Hospital (OUS), Oslo, Norway. jens.pahnke@medisin.uio.no.

Drugs R D ; 20(3): 197-207, 2020 Sep.

Article in En | MEDLINE | ID: mdl-32696271

Subject(s)

Fingolimod Hydrochloride/therapeutic use; Nervous System Diseases/drug therapy; Sphingosine 1 Phosphate Receptor Modulators/therapeutic use; Alzheimer Disease/drug therapy; Animals; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Disease Models, Animal; Drug Evaluation, Preclinical; Epilepsy/drug therapy; Humans; Lymphocytes/metabolism; Mice; Multiple Sclerosis/drug therapy; Neuroprotective Agents/therapeutic use; Rats

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Fingolimod Hydrochloride / Sphingosine 1 Phosphate Receptor Modulators / Nervous System Diseases Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Drugs R D Journal subject: TERAPIA POR MEDICAMENTOS Year: 2020 Document type: Article Affiliation country: Norway Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google